GlassScriptPhysician profile
Melissa T Garrett
NPI 1881910271
$25,282.25
in general payments reported to CMS, 2019-2025
29 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $26.35 · 2021: $256 · 2022: $19K · 2023: $3,401 · 2024: $2,134 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,068 · Food and Beverage: $1,438 · Travel and Lodging: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,068.49 |
| Food and Beverage | $1,438.42 |
| Travel and Lodging | $1,333.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,988.17 | 2021-2023 | Davinci Xi |
| Zimmer Biomet Holdings, INC. | $1,650.14 | 2019-2024 | Advantagerib |
| Phathom Pharmaceuticals, INC. | $346.35 | 2024-2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $124.88 | 2021-2024 | Gattex |
| Tela Bio, INC. | $102.69 | 2020-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $89.66 | 2021-2023 | Progrip |
| Davol INC. | $84.87 | 2021-2024 | Arista Ah Flexitip |
| Csl Behring | $82.27 | 2019-2025 | Kcentra |
| Merck Sharp & Dohme LLC | $81.05 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $77.32 | 2024-2025 | |
| Ethicon US, LLC | $72.72 | 2019-2024 | Stratafix |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Lemaitre Vascular, INC. | $64.13 | 2023-2024 | Artegraft Vascular Graft, Anastoclip Gc 8cm (Medium) |
| Braintree Laboratories, INC. | $61.40 | 2021-2023 | Suflave, Sutab |
| Atricure, INC. | $48.95 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $48.84 | 2019-2021 | |
| Innovation Technologies INC | $38.52 | 2023 | Irrisept |
| Smith+Nephew, INC. | $37.06 | 2022-2025 | Stravix, Grafix Pl |
| Bard Peripheral Vascular, INC. | $31.90 | 2024-2025 | Glidepath |
| Stryker Corporation | $30.69 | 2022 | |
| Becton, Dickinson and Company | $26.02 | 2023 | Phasix Mesh |
| Kerecis Limited | $19.53 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kls-Martin L.P. | $17.72 | 2024 | |
| Heron Therapeutics, INC. | $16.65 | 2023 | Zynrelef |
| Reprise Biomedical, INC. | $16.50 | 2025 | Mirotract |
| Acera Surgical, INC. | $16.19 | 2022 | |
| Boston Scientific Corporation | $14.65 | 2021 | |
| Solventum Corporation | $13.13 | 2024 | Prevena |
| Tei Biosciences INC | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.